Moderna Inc. buy UBS Group AG
Start price
26.06.23
/
50%
€111.22
Target price
26.06.24
€174.90
Performance (%)
-6.35%
Price
29.04.24
€104.16
Summary
This prediction is currently active. With a performance of -6.35%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 26.06.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | 6.188% | 6.188% |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $191.00 price target on the stock, down previously from $221.00.
Ratings data for MRNA provided by MarketBeat